Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025-4

Incidence and severity of hand-foot syndrome in cancer patients receiving infusional 5-fluorouracil or oral capecitabine-containing chemotherapy regimens

Sulaikha Abdul Kareem, Simi Grace Joseph, Aneena Wilson [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2016-6

Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review

Seyyedeh S Saneeymehri, Kelly R Markey, Amit Mahipal

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2016-10

A first case report of diffuse acneiform eruption caused by capecitabine in a patient with small-cell neuroendocrine lung carcinoma

Asude Kara, EmineTugba Alatas, Gursoy Dogan [...]

Journal of Oncology Pharmacy Practice

Retricted access

Other

First published 2010-6

Capecitabine-induced pancreatitis

Hanifi Yucel, Laurence V Warmerdam

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2022-1

A case of palmar hypopigmentation induced by capecitabine in a gastrointestinal cancer patient

Julian Gratiaux, Chloé Gossery, Chirine Rezzag-Mahcene [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2022-1

Capecitabine induced Steven–Johnson syndrome: A rare case report

Kavya Karthikeyan, K V Sameera, Shintu Shaji [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024

Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database

Rongqiang Liu, Yukai Chen, Shi-Nan Wu [...]

Therapeutic Advances in Drug Safety

Retricted access

Case report

First published 2012-3

A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysis

Kenar D Jhaveri, Carlos Flombaum, Manish Shah [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2023-4

Diurnal Changes in Capecitabine Clock-Controlled Metabolism Enzymes Are Responsible for Its Pharmacokinetics in Male Mice

Yasemin Kubra Akyel, Dilek Ozturk Civelek, Narin Ozturk Seyhan [...]

Journal of Biological Rhythms

Retricted access

Research article

First published 2002-03

Capecitabine: a novel,orally administered,tumour-activated treatment for breast cancer

Maxwell Summerhayes

Journal of Oncology Pharmacy Practice

Search results